Browsing Category
Bioavailability enhancement
Transdermal formulations and strategies for the treatment of osteoporosis
Osteoporosis is a silent and growing disease that constitutes a major health issue, due to its association with an elevated risk of fractures, morbidity, mortality, and re-hospitalization, along with the big financial burden involved. Drugs used in the treatment of this condition are administered…
Read More...
Read More...
Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods
An increasing proportion of new medicinal substances are poorly soluble in water. Adsorption on mesoporous silicas increases their bioavailability when administered orally. Loading method determines adsorption either on the surface in crystalline state or inside the mesopores in amorphous form. The…
Read More...
Read More...
Tablet Disintegration and Dispersion under In Vivo-like Hydrodynamic Conditions
Disintegration and dispersion are functional properties of tablets relevant for the desired API release. The standard disintegration test (SDT) described in different pharmacopoeias provides only limited information on these complex processes. It is considered not to be comparable to the biorelevant…
Read More...
Read More...
The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development
Nanomedicine plays an essential role in developing new therapies through novel drug delivery systems, diagnostic and imaging systems, vaccine development, antibacterial tools, and high-throughput screening. One of the most promising drug delivery systems are nanoparticles, which can be designed with…
Read More...
Read More...
ExciPerience – Early Bird sale ends on January 31st
ExciPerience is the virtual event around every aspect of pharmaceutical excipients. ExciPerience covers all areas from basic or advanced research and formulation to manufacturing and regulatory. There will be more and new possibilities for personal interaction and different presentation formats than…
Read More...
Read More...
Development and evaluation of nano-formulations for immediate release oral dosage forms of poorly…
Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry, Pharmacy of Freie Universität Berlin by Zun Huang
Solubility and dissolution rate are essential for the oral absorption and thus bioavailability of…
Read More...
Read More...
Lipid-based nanocarriers for oral delivery of peptides
Therapeutic peptides can treat a wide variety of diseases with selective and potent action. Their oral bioavailability is strongly limited by an important proteolytic activity in the intestinal lumen and poor permeation across the intestinal border. We have evaluated the capacity of solid lipid…
Read More...
Read More...
Reality augmented by Gattefossé
Augmented reality in oral bioavailability enhancement arena:
Labrafac™ MC60, glycerol monocaprylocaprate
Gattefossé widens its range of high quality, functional excipients for oral bioavailability enhancement with Labrafac™ MC60, glycerol monocaprylocaprate.
The chemistry of this…
Read More...
Read More...
Effect of Soluplus® on γ-cyclodextrin solubilization of irbesartan and candesartan and their…
The poor aqueous solubility of irbesartan (IRB) and candesartan cilexetil (CAC) may hamper their bioavailability when orally or topically administered. Among several attempts, the promising nanoaggregate formation by γ-cyclodextrin (γCD) complexation of drugs in aqueous solution with or without…
Read More...
Read More...
Ball milling and hot-melt extrusion of indomethacin–L-arginine–vinylpyrrolidone-vinyl acetate…
Commonly applied approaches to enhance the dissolution properties of low water-soluble crystalline active pharmaceutical ingredients (APIs) include their amorphization by incorporation into a polymeric matrix and the formation of amorphous solid dispersions (ASDs), or blending APIs with…
Read More...
Read More...